Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
A new income model uses a $560,000 portfolio built from covered-call ETFs, preferred shares, and BDCS to generate abo...
A veteran hedge-fund manager behind an early SpaceX investment argues the AI-driven bottleneck trade is fading, trigg...
Meta Platforms signals a cloud compute push, aiming to sell AI capacity directly to enterprises amid a record capex c...
Policy clarity clears the path for road ahead build-to-rent projects, lifting investor confidence. Still, the pace of...
When a fund trims large holdings, it can signal shifting risk and opportunity. This article explains why an investmen...
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
Constellation Energy plunged today after a mix of macro moves and strategic shifts. This guide breaks down the factor...
Investing in rare earths sits at the intersection of policy, manufacturing demand, and new mining projects. This guid...
Teva has climbed more than 100% in the last year, and analysts remain cautiously optimistic. Here’s why wall street t...
A prominent hedge fund just sold its entire XPeng stake, triggering questions for everyday investors. Learn how to ev...
NVIDIA has moved beyond gaming GPUs to become a cornerstone of the AI era. This shift, described by some as NVIDIA ju...